Skip to main content

Green Star Products: Ready to Close COVID-19 Contract at Shareholders Meeting

Written by Customer Service on . Posted in Public Companies.

SALT LAKE CITY, UT, Feb. 26, 2021 (GLOBE NEWSWIRE) — Today, Mr. Joseph LaStella, President of Green Star Products, Inc. (USOTC: GSPI) stated, “The Company has enough early votes to close the COVID-19 contract with BTR (Biotech Research, LLC).” The Company has already received 52% of our shareholder’s votes, and over 90% have voted in favor of approving the exclusive licensing with Biotech Research.
This approval ensures the final passage of the contract between Green Star Products and Biotech Research at the shareholders meeting. GSPI can now move ahead with this exclusive distribution agreement. For more details, please see press release dated December 21, 2020, titled: “Green Star Products: New Research Data Indicates 99.9% Effective Against The COVID-19 Virus.”The 2021 Special Shareholders Meeting is scheduled on March 3, 2021, 9 am PST to 12 PM PST. Due to the COVID-19 pandemic, Green Star Products will not be holding an actual in-person stockholders meeting. For information about the meeting go to our website https://gspiusa.com/ or directly to our meeting web page https://gspiusa.com/shareholders-meeting. In that web page you can find a Letter to Our Stockholders with current information about Company operations, voting updates, and a Special Shareholder’s Discount Coupon Code for Viro Spectrum Shield (VSS) purchases and some information about this great anti-viral product.At the present time, our Company is concentrating all its efforts on distribution of Viro Spectrum Shield, as it is of utmost importance that we help save lives during this active pandemic. COVID-19 is mutating quickly and spreading throughout the world. VSS has been successfully tested against multiple viruses. It tested at 99.9% efficacy against the COVID-19 virus in vitro. Results verified by a United States Federally Accredited Laboratory prove that VSS is non-toxic and has shown Broad-Spectrum Antiviral capabilities.So many benefits to VSS, none more important than this formula can be used to combat the virus after infection as well as an all-natural preventative. Volunteers who were ill as a result of virus, many testing positive for the COVID-19 virus, used VSS and showed reversal of symptoms in 24-72 hours. See https://vssmt.net/ for more information. VSS makes no claims, the evidence speaks for itself!Please hear recent audio interview testimonials at:https://drive.google.com/file/d/1XKDtltbVZ9NkBJe__Oj-S3nRkFR-rBLf/viewhttps://drive.google.com/file/d/12ldjTbYOuioBxnelHdA5reGc8nC5RJ_f/viewAbout Green Star ProductsGreen Star Products, Inc. (PINKSHEETS: GSPI) is an environmentally friendly Public Company creating innovative and cost-effective products to improve the quality of life and the environment.Forward-looking statements are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such statements involve risks and uncertainties, including without limitation, continued acceptance of the Company’s products, its dependence on third-party suppliers, and other risks detailed from time to time in the Company’s periodic filings.CONTACT:
Joseph LaStella, President
Green Star Products, Inc.
(406) 360-5019
joe@jplastella.com
https://gspiusa.com/

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.